Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other

Clonal Immunoglobulin Heavy Chain Gene Rearrangement

Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Stage IIA Lung Small Cell Carcinoma AJCC v7

C-KIT Tyrosine Kinase Protein Overexpression || RB1 Gene Inactivation || TP53 Gene Inactivation || FGFR1 Gene Amplification || NMYC Gene Amplification || PTEN Gene Mutation


Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA

FIP1L1-PDGFRalpha Fusion Protein Expression


Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement


Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm

BRAF Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation


SS18-SSX1 Fusion Protein Expression
SS18-SSX2 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression

SS18-SSX1 Fusion Protein Expression || SS18-SSX2 Fusion Protein Expression || SS18-SSX4 Fusion Protein Expression


Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Thyroid Gland Papillary Carcinoma by AJCC v7 Stage

NRAS Gene Mutation
KRAS Gene Mutation
RET/PTC Rearrangement
NTRK1 Gene Rearrangement
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || KRAS Gene Mutation || RET/PTC Rearrangement || NTRK1 Gene Rearrangement || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


Fibrin-Associated Diffuse Large B-Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Gastric Mucosa-Associated Lymphoid Tissue Lymphoma


Rectal Carcinoma Metastatic in the Liver

BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Metastatic Gastrointestinal Stromal Tumor

PDGFRA Gene Mutation || KIT Gene Mutation


C-KIT Somatic Point Mutation || C-KIT Tyrosine Kinase Protein Overexpression


Plurimorphous Plurihormonal Pituitary Gland Adenoma

Pituitary Tumor Transforming Gene Overexpression


Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Clonal Immunoglobulin Heavy Chain Gene Rearrangement


Cortisol-Producing Adrenal Cortex Adenoma


Stage IIIB Gastric Gastrointestinal Stromal Tumor


Microsatellite Instability
CTNNB1 Gene Mutation
PTEN Gene Inactivation

Microsatellite Instability || CTNNB1 Gene Mutation || PTEN Gene Inactivation


Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


CDH1 Gene Inactivation
Loss of E-cadherin Expression

CDH1 Gene Inactivation || Loss of E-cadherin Expression


Pancreatic Moderately Differentiated Ductal Adenocarcinoma

BRCA2 Gene Mutation
CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
ERBB2 Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
AKT2 Gene Amplification
KRAS Gene Mutation
MAP2K4 Gene Inactivation

BRCA2 Gene Mutation || CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || ERBB2 Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || AKT2 Gene Amplification || KRAS Gene Mutation || MAP2K4 Gene Inactivation


Stage IIB Lung Non-Small Cell Carcinoma AJCC v7

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation

FIP1L1-PDGFRalpha Fusion Protein Expression


Mixed Cell Type Gastrointestinal Stromal Tumor


Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type


Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement

Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Stage IV Nasopharyngeal Carcinoma AJCC v7

CDKN2A Gene Inactivation
RASSF1A Gene Inactivation

CDKN2A Gene Inactivation || RASSF1A Gene Inactivation


Clonal CCND1 Gene Rearrangement
CCND1 Protein Overexpression

Clonal CCND1 Gene Rearrangement || CCND1 Protein Overexpression


EGFR Gene Amplification
EGFR Protein Overexpression
TP53 Gene Inactivation
MDM2 Gene Amplification
PDGFRA Gene Mutation
PDGFRalpha Protein Overexpression
PTEN Gene Inactivation

EGFR Gene Amplification || EGFR Protein Overexpression || TP53 Gene Inactivation || MDM2 Gene Amplification || PDGFRA Gene Mutation || PDGFRalpha Protein Overexpression || PTEN Gene Inactivation


B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1

p190 Fusion Protein Expression || p210 Fusion Protein Expression || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Pituitary Tumor Transforming Gene Overexpression


Metastatic Lung Non-Small Cell Squamous Carcinoma

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
EGFR Gene Mutation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || EGFR Gene Mutation


Stage I Adrenal Cortex Carcinoma AJCC v7


Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || PDCD1LG2 Gene Overexpression


Clear Cell Variant Thyroid Gland Follicular Carcinoma

NRAS Gene Mutation
PTEN Gene Inactivation
PPARG Gene Rearrangement
HRAS Gene Mutation
PIK3CA Gene Mutation
TERT Gene Mutation

NRAS Gene Mutation || PTEN Gene Inactivation || PPARG Gene Rearrangement || HRAS Gene Mutation || PIK3CA Gene Mutation || TERT Gene Mutation


Signet Ring Cell Intrahepatic Cholangiocarcinoma

TP53 Gene Inactivation
KRAS Gene Amplification

TP53 Gene Inactivation || KRAS Gene Amplification

FIP1L1-PDGFRalpha Fusion Protein Expression


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7

EGFR Protein Overexpression
TP53 Gene Inactivation
ERBB2 Protein Overexpression

EGFR Protein Overexpression || TP53 Gene Inactivation || ERBB2 Protein Overexpression


Lung Large Cell Carcinoma by AJCC v7 Stage

TP53 Gene Inactivation
KRAS Gene Mutation
EGFR Gene Mutation

TP53 Gene Inactivation || KRAS Gene Mutation || EGFR Gene Mutation


Myelodysplastic Syndrome with Somatic Mutations

TP53 Gene Inactivation
RUNX1 Gene Mutation
EZH2 Gene Mutation
ETV6 Gene Mutation
ASXL1 Gene Mutation

TP53 Gene Inactivation || RUNX1 Gene Mutation || EZH2 Gene Mutation || ETV6 Gene Mutation || ASXL1 Gene Mutation

FIP1L1-PDGFRalpha Fusion Protein Expression


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Anaplastic (Malignant) Intracranial Meningioma


T-Cell Large Granular Lymphocyte Leukemia, Common Variant


Cardiac Inflammatory Myofibroblastic Tumor

CLTC-ALK Fusion Protein Expression
TPM3-ALK Fusion Protein Expression
TPM4-ALK Fusion Protein Expression

CLTC-ALK Fusion Protein Expression || TPM3-ALK Fusion Protein Expression || TPM4-ALK Fusion Protein Expression


Stage III Lentigo Maligna Melanoma AJCC v7


Skin Sclerosing/Morphoeic Basal Cell Carcinoma


SS18-SSX1 Fusion Protein Expression
SS18-SSX2 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression

SS18-SSX1 Fusion Protein Expression || SS18-SSX2 Fusion Protein Expression || SS18-SSX4 Fusion Protein Expression


Cervical Squamous Cell Carcinoma In Situ


Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


Splenic Manifestation of Chronic Lymphocytic Leukemia


Recurrent Superficial Bladder Urothelial Carcinoma

CCND1 Gene Amplification
CCND1 Protein Overexpression
EGFR Gene Amplification
EGFR Protein Overexpression
ERBB2 Gene Amplification
HRAS Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
ERBB2 Protein Overexpression
MDM2 Gene Amplification

CCND1 Gene Amplification || CCND1 Protein Overexpression || EGFR Gene Amplification || EGFR Protein Overexpression || ERBB2 Gene Amplification || HRAS Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || ERBB2 Protein Overexpression || MDM2 Gene Amplification


Laryngeal Inflammatory Myofibroblastic Tumor


Stage IIA Cutaneous Melanoma AJCC v6 and v7


TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7

NRAS Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation
PTEN Gene Inactivation
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation || PTEN Gene Inactivation || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage

PDGFRA Gene Mutation || KIT Gene Mutation


EWSR1-NR4A3 Fusion Protein Expression
TAF15-NR4A3 Fusion Protein Expression
TCF12-NR4A3 Fusion Protein Expression
TFG-NR4A3 Fusion Protein Expression

EWSR1-NR4A3 Fusion Protein Expression || TAF15-NR4A3 Fusion Protein Expression || TCF12-NR4A3 Fusion Protein Expression || TFG-NR4A3 Fusion Protein Expression


Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation


High Grade B-Cell Lymphoma, Not Otherwise Specified

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Stage IV Thyroid Gland Follicular Carcinoma AJCC v7

NRAS Gene Mutation
PTEN Gene Inactivation
PPARG Gene Rearrangement
HRAS Gene Mutation
PIK3CA Gene Mutation
TERT Gene Mutation

NRAS Gene Mutation || PTEN Gene Inactivation || PPARG Gene Rearrangement || HRAS Gene Mutation || PIK3CA Gene Mutation || TERT Gene Mutation


Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma

CDKN2A Gene Inactivation
ERBB2 Gene Amplification
TP53 Gene Inactivation
KRAS Gene Mutation

CDKN2A Gene Inactivation || ERBB2 Gene Amplification || TP53 Gene Inactivation || KRAS Gene Mutation


NRAS Gene Mutation
KRAS Gene Mutation
PPARG Gene Rearrangement
HRAS Gene Mutation

NRAS Gene Mutation || KRAS Gene Mutation || PPARG Gene Rearrangement || HRAS Gene Mutation


Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


EGFR Gene Amplification
EGFR Protein Overexpression
TP53 Gene Inactivation
MDM2 Gene Amplification
PDGFRA Gene Mutation
PDGFRalpha Protein Overexpression
PTEN Gene Inactivation

EGFR Gene Amplification || EGFR Protein Overexpression || TP53 Gene Inactivation || MDM2 Gene Amplification || PDGFRA Gene Mutation || PDGFRalpha Protein Overexpression || PTEN Gene Inactivation


Stage IB2 Cervical Cancer AJCC v6 and v7

ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


Advanced Lung Non-Small Cell Squamous Carcinoma

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
EGFR Gene Mutation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || EGFR Gene Mutation


Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7


Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

EVI1-AML1 Fusion Protein Expression
p190 Fusion Protein Expression
p210 Fusion Protein Expression
p230 Fusion Protein Expression

EVI1-AML1 Fusion Protein Expression || p190 Fusion Protein Expression || p210 Fusion Protein Expression || p230 Fusion Protein Expression


Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia


Metastatic Small Intestinal Adenocarcinoma

Microsatellite Instability
CTNNB1 Gene Mutation
SMAD4/DPC4 Gene Inactivation
TP53 Gene Inactivation
KRAS Gene Mutation
Loss of E-cadherin Expression

Microsatellite Instability || CTNNB1 Gene Mutation || SMAD4/DPC4 Gene Inactivation || TP53 Gene Inactivation || KRAS Gene Mutation || Loss of E-cadherin Expression


Ductal Breast Carcinoma In Situ, Solid Type

CCND1 Gene Amplification
Cyclin D1 Messenger RNA Overexpression
CCND1 Protein Overexpression
ERBB2 Gene Amplification
TP53 Gene Inactivation
ERBB2 Protein Overexpression

CCND1 Gene Amplification || Cyclin D1 Messenger RNA Overexpression || CCND1 Protein Overexpression || ERBB2 Gene Amplification || TP53 Gene Inactivation || ERBB2 Protein Overexpression


Pituitary Tumor Transforming Gene Overexpression


Salivary Gland Diffuse Large B-Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement

Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Borderline Ovarian Mucinous Tumor, Endocervical-Like


Locally Advanced Pituitary Gland Carcinoma


EWSR1-ETV4 Fusion Protein Expression
EWSR1-ERG Fusion Protein Expression
EWSR1-ETV1 Fusion Protein Expression
EWSR1-FEV Fusion Protein Expression
EWSR1-PATZ1 Fusion Protein Expression
FUS-ERG Fusion Protein Expression
EWSR1-FLI1 Fusion Protein Expression

EWSR1-ETV4 Fusion Protein Expression || EWSR1-ERG Fusion Protein Expression || EWSR1-ETV1 Fusion Protein Expression || EWSR1-FEV Fusion Protein Expression || EWSR1-PATZ1 Fusion Protein Expression || FUS-ERG Fusion Protein Expression || EWSR1-FLI1 Fusion Protein Expression


Stage IB Lung Non-Small Cell Carcinoma AJCC v7

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


Alcohol-Related Esophageal Squamous Cell Carcinoma

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation


Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


Thoracic Esophagus Squamous Cell Carcinoma

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Central Nervous System Langerhans Cell Histiocytosis


Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7

Clonal T-Cell Receptor Beta Chain Gene Rearrangement


Microsatellite Instability
CDH1 Gene Inactivation
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
c-MET Gene Amplification

Microsatellite Instability || CDH1 Gene Inactivation || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || c-MET Gene Amplification


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement


Stage IIIB Esophageal Adenocarcinoma AJCC v7


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


C-KIT Tyrosine Kinase Protein Overexpression || KIT Gene Mutation


Advanced Pancreatic Ductal Adenocarcinoma

BRCA2 Gene Mutation
CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
ERBB2 Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
AKT2 Gene Amplification
KRAS Gene Mutation
MAP2K4 Gene Inactivation

BRCA2 Gene Mutation || CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || ERBB2 Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || AKT2 Gene Amplification || KRAS Gene Mutation || MAP2K4 Gene Inactivation


Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma

CDH1 Gene Inactivation
Loss of E-cadherin Expression

CDH1 Gene Inactivation || Loss of E-cadherin Expression


Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements

CCND1 Gene Amplification
CCND1 Protein Overexpression
EGFR Gene Amplification
EGFR Protein Overexpression
ERBB2 Gene Amplification
HRAS Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
ERBB2 Protein Overexpression
MDM2 Gene Amplification

CCND1 Gene Amplification || CCND1 Protein Overexpression || EGFR Gene Amplification || EGFR Protein Overexpression || ERBB2 Gene Amplification || HRAS Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || ERBB2 Protein Overexpression || MDM2 Gene Amplification


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Stage III Adrenal Cortex Carcinoma AJCC v7


Stage II Lung Squamous Cell Carcinoma AJCC v7

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation


Stage III Intrahepatic Cholangiocarcinoma AJCC v7

TP53 Gene Inactivation
KRAS Gene Amplification

TP53 Gene Inactivation || KRAS Gene Amplification


Clonal Immunoglobulin Heavy Chain Gene Rearrangement

Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Ciliary Body Benign Teratoid Medulloepithelioma


Resectable Lung Non-Small Cell Carcinoma

TP53 Gene Inactivation
EGFR Gene Mutation


Aleukemic Acute Lymphoblastic Leukemia Cutis

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8

GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


Ciliary Body Malignant Medulloepithelioma


Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder

Clonal Immunoglobulin Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


SS18-SSX1 Fusion Protein Expression
SS18-SSX2 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression

SS18-SSX1 Fusion Protein Expression || SS18-SSX2 Fusion Protein Expression || SS18-SSX4 Fusion Protein Expression


Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation


Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

EWSR1-ETV4 Fusion Protein Expression
EWSR1-ERG Fusion Protein Expression
EWSR1-ETV1 Fusion Protein Expression
EWSR1-FEV Fusion Protein Expression
EWSR1-PATZ1 Fusion Protein Expression
FUS-ERG Fusion Protein Expression
EWSR1-FLI1 Fusion Protein Expression

EWSR1-ETV4 Fusion Protein Expression || EWSR1-ERG Fusion Protein Expression || EWSR1-ETV1 Fusion Protein Expression || EWSR1-FEV Fusion Protein Expression || EWSR1-PATZ1 Fusion Protein Expression || FUS-ERG Fusion Protein Expression || EWSR1-FLI1 Fusion Protein Expression


Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant


Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8

Clonal T-Cell Receptor Beta Chain Gene Rearrangement

Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Stage III Lung Squamous Cell Carcinoma AJCC v7


Serous Endometrial Intraepithelial Carcinoma


Metastatic Endometrial Serous Adenocarcinoma


Diffuse Large B-Cell Lymphoma Activated B-Cell Type


Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


BRAF Gene Mutation || High-Frequency Microsatellite Instability || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Pleural Malignant Mesothelioma by AJCC v7 Stage

CDKN2A Gene Inactivation
GPC3 Gene Inactivation
NF2 Gene Mutation

CDKN2A Gene Inactivation || GPC3 Gene Inactivation || NF2 Gene Mutation


Stage IIB Lung Squamous Cell Carcinoma AJCC v7

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation


Human Papillomavirus-Related Anal Squamous Cell Carcinoma

TP53 Gene Inactivation
MYC Gene Amplification

TP53 Gene Inactivation || MYC Gene Amplification


TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
KRAS Gene Amplification
LKB1 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || KRAS Gene Amplification || LKB1 Gene Inactivation || EGFR Gene Mutation


Recurrent B Acute Lymphoblastic Leukemia

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Childhood T Acute Lymphoblastic Leukemia

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement || NOTCH1 Gene Mutation


Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7

NRAS Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation
PTEN Gene Inactivation
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation || PTEN Gene Inactivation || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


EGFR Gene Amplification
EGFR Protein Overexpression
PDGFRA Gene Mutation
PDGFRalpha Protein Overexpression
PTEN Gene Inactivation

EGFR Gene Amplification || EGFR Protein Overexpression || PDGFRA Gene Mutation || PDGFRalpha Protein Overexpression || PTEN Gene Inactivation


TMPRSS2-ERG Fusion Protein Expression
ERG Gene Rearrangement

TMPRSS2-ERG Fusion Protein Expression || ERG Gene Rearrangement


Stage IIIB Pleural Malignant Mesothelioma AJCC v8


Stage II Lentigo Maligna Melanoma AJCC v6 and v7


Prostate Acinar Adenocarcinoma, Pseudohyperplastic Variant

TP53 Gene Inactivation
PTEN Gene Inactivation
TMPRSS2-ERG Fusion Protein Expression
ERG Gene Rearrangement

TP53 Gene Inactivation || PTEN Gene Inactivation || TMPRSS2-ERG Fusion Protein Expression || ERG Gene Rearrangement


Peritoneal Gastrointestinal Stromal Tumor

PDGFRA Gene Mutation || KIT Gene Mutation


Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


Stage II Lung Non-Small Cell Cancer AJCC v7

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


Thyroid Gland Papillary Carcinoma by AJCC v7 Stage

NRAS Gene Mutation
KRAS Gene Mutation
RET/PTC Rearrangement
NTRK1 Gene Rearrangement
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || KRAS Gene Mutation || RET/PTC Rearrangement || NTRK1 Gene Rearrangement || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor


Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Lung Keratinizing Squamous Cell Carcinoma

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation


Pancreatic Moderately Differentiated Ductal Adenocarcinoma

BRCA2 Gene Mutation
CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
ERBB2 Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
AKT2 Gene Amplification
KRAS Gene Mutation
MAP2K4 Gene Inactivation

BRCA2 Gene Mutation || CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || ERBB2 Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || AKT2 Gene Amplification || KRAS Gene Mutation || MAP2K4 Gene Inactivation


T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta


Microsatellite Instability
BRAF Gene Mutation

Microsatellite Instability || BRAF Gene Mutation


Ann Arbor Stage IV Adult Lymphoblastic Lymphoma

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Primary Bone Diffuse Large B-Cell Lymphoma


Invasive Lobular Breast Carcinoma with Predominant In Situ Component

CDH1 Gene Inactivation
Loss of E-cadherin Expression

CDH1 Gene Inactivation || Loss of E-cadherin Expression


Clonal CCND1 Gene Rearrangement
CCND1 Protein Overexpression

Clonal CCND1 Gene Rearrangement || CCND1 Protein Overexpression


Stage II Small Intestinal Adenocarcinoma AJCC v8

Microsatellite Instability
CTNNB1 Gene Mutation
SMAD4/DPC4 Gene Inactivation
TP53 Gene Inactivation
KRAS Gene Mutation
Loss of E-cadherin Expression

Microsatellite Instability || CTNNB1 Gene Mutation || SMAD4/DPC4 Gene Inactivation || TP53 Gene Inactivation || KRAS Gene Mutation || Loss of E-cadherin Expression


BRAF Gene Mutation || High-Frequency Microsatellite Instability || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Clonal Immunoglobulin Heavy Chain Gene Rearrangement


Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Recurrent Systemic Anaplastic Large Cell Lymphoma


Resectable Pancreatic Ductal Adenocarcinoma


Stage I Lung Large Cell Carcinoma AJCC v7

TP53 Gene Inactivation
KRAS Gene Mutation
EGFR Gene Mutation

TP53 Gene Inactivation || KRAS Gene Mutation || EGFR Gene Mutation


Aneuploidy
CCND1 Gene Amplification
CCND1 Protein Overexpression
CDC73 Gene Mutation

Aneuploidy || CCND1 Gene Amplification || CCND1 Protein Overexpression || CDC73 Gene Mutation


Stage III Esophageal Adenocarcinoma AJCC v7

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


Salivary Gland Diffuse Large B-Cell Lymphoma


Stage IIIA Lung Large Cell Carcinoma AJCC v7


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Spindle Cell Variant Thyroid Gland Papillary Carcinoma

NRAS Gene Mutation
KRAS Gene Mutation
RET/PTC Rearrangement
NTRK1 Gene Rearrangement
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || KRAS Gene Mutation || RET/PTC Rearrangement || NTRK1 Gene Rearrangement || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


Lung Squamous Cell Carcinoma by AJCC v7 Stage

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation


Metastatic Lung Non-Small Cell Carcinoma


Pituitary Tumor Transforming Gene Overexpression


CCND1 Gene Amplification
Cyclin D1 Messenger RNA Overexpression
CCND1 Protein Overexpression
ERBB2 Gene Amplification
TP53 Gene Inactivation
ERBB2 Protein Overexpression

CCND1 Gene Amplification || Cyclin D1 Messenger RNA Overexpression || CCND1 Protein Overexpression || ERBB2 Gene Amplification || TP53 Gene Inactivation || ERBB2 Protein Overexpression


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Refractory Diffuse Large B-Cell Lymphoma


Metastatic Lung Non-Small Cell Squamous Carcinoma

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
EGFR Gene Mutation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || EGFR Gene Mutation


Minimally Invasive Lung Mucinous Adenocarcinoma

TP53 Gene Inactivation
KRAS Gene Amplification
LKB1 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || KRAS Gene Amplification || LKB1 Gene Inactivation || EGFR Gene Mutation


TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Mutation

TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Mutation


Locally Advanced Prostate Neuroendocrine Carcinoma

TMPRSS2-ERG Fusion Protein Expression
ERG Gene Rearrangement

TMPRSS2-ERG Fusion Protein Expression || ERG Gene Rearrangement


Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Unresectable Pleural Malignant Mesothelioma

CDKN2A Gene Inactivation
GPC3 Gene Inactivation
NF2 Gene Mutation

CDKN2A Gene Inactivation || GPC3 Gene Inactivation || NF2 Gene Mutation


Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia


Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


Stage IIIA Lung Non-Small Cell Cancer AJCC v7


Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma

BRAF Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation


Unresectable Pleural Biphasic Mesothelioma

CDKN2A Gene Inactivation
NF2 Gene Inactivation
GPC3 Gene Inactivation
NF2 Gene Mutation
BAP1 Gene Mutation

CDKN2A Gene Inactivation || NF2 Gene Inactivation || GPC3 Gene Inactivation || NF2 Gene Mutation || BAP1 Gene Mutation


C-KIT Tyrosine Kinase Protein Overexpression || KIT Gene Mutation


BRAF Gene Mutation || High-Frequency Microsatellite Instability || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Common Variant Anaplastic Large Cell Lymphoma


Recurrent Oral Cavity Mucoepidermoid Carcinoma


Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma


Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement || NOTCH1 Gene Mutation


C-KIT Tyrosine Kinase Protein Overexpression


Pancreatic Acinar Cell Cystadenocarcinoma


Advanced Lung Non-Small Cell Squamous Carcinoma


BRAF Gene Mutation || KRAS Gene Mutation


Refractory Pleural Malignant Mesothelioma


Advanced Esophageal Squamous Cell Carcinoma

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


TP53 Gene Mutation
NF1 Gene Mutation
CDKN2A Gene Mutation

TP53 Gene Mutation || NF1 Gene Mutation || CDKN2A Gene Mutation


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation
Loss of E-cadherin Expression

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation || Loss of E-cadherin Expression


ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7


GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


TSC1 Gene Inactivation
TSC2 Gene Inactivation

TSC1 Gene Inactivation || TSC2 Gene Inactivation


Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Ann Arbor Stage IV Grade 3 Follicular Lymphoma

Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement


HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


Stage IV Prostate Adenocarcinoma AJCC v7

TMPRSS2-ERG Fusion Protein Expression
ERG Gene Rearrangement

TMPRSS2-ERG Fusion Protein Expression || ERG Gene Rearrangement


Thyroid Gland Follicular Adenoma with Papillary Hyperplasia

NRAS Gene Mutation
KRAS Gene Mutation
HRAS Gene Mutation

NRAS Gene Mutation || KRAS Gene Mutation || HRAS Gene Mutation


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Ciliary Body Teratoid Medulloepithelioma


High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant


Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8

NRAS Gene Mutation
PTEN Gene Inactivation
PPARG Gene Rearrangement
HRAS Gene Mutation
PIK3CA Gene Mutation
TERT Gene Mutation

NRAS Gene Mutation || PTEN Gene Inactivation || PPARG Gene Rearrangement || HRAS Gene Mutation || PIK3CA Gene Mutation || TERT Gene Mutation


Stage IB Lung Non-Small Cell Carcinoma AJCC v7

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


B Acute Lymphoblastic Leukemia with t(4;11)(q21;23)


TP53 Gene Inactivation
MYC Gene Amplification

TP53 Gene Inactivation || MYC Gene Amplification


Rectal Carcinoma Metastatic in the Liver


Ann Arbor Stage I Adult Immunoblastic Lymphoma

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma


EGFR Protein Overexpression || Pituitary Tumor Transforming Gene Overexpression || USP8 Gene Mutation


Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


Ann Arbor Stage II Grade 2 Follicular Lymphoma


Advanced Pancreatic Ductal Adenocarcinoma

BRCA2 Gene Mutation
CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
ERBB2 Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
AKT2 Gene Amplification
KRAS Gene Mutation
MAP2K4 Gene Inactivation

BRCA2 Gene Mutation || CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || ERBB2 Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || AKT2 Gene Amplification || KRAS Gene Mutation || MAP2K4 Gene Inactivation


B-Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21


Gastrointestinal Stromal Tumor of Uncertain Malignant Potential

PDGFRA Gene Mutation || KIT Gene Mutation


Stage III Adrenal Cortex Carcinoma AJCC v8


C-KIT Tyrosine Kinase Protein Overexpression || KIT Gene Mutation


Stage II Nasopharyngeal Carcinoma AJCC v6

CDKN2A Gene Inactivation
RASSF1A Gene Inactivation

CDKN2A Gene Inactivation || RASSF1A Gene Inactivation


Acute Lymphoblastic Leukemia by ROSE Cluster

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement


Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation


Stage IIIA Esophageal Adenocarcinoma AJCC v7

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Thyroid Gland Follicular Carcinoma by AJCC v7 Stage


Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor


Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma

CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
TP53 Gene Inactivation
KRAS Gene Mutation

CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || TP53 Gene Inactivation || KRAS Gene Mutation


Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type

ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Stage II Pleural Malignant Mesothelioma AJCC v7

CDKN2A Gene Inactivation
GPC3 Gene Inactivation
NF2 Gene Mutation

CDKN2A Gene Inactivation || GPC3 Gene Inactivation || NF2 Gene Mutation


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Ann Arbor Stage IV Small Lymphocytic Lymphoma


Lung Large Cell Neuroendocrine Carcinoma

CDKN2A Gene Deletion || C-KIT Tyrosine Kinase Protein Overexpression || RB1 Gene Inactivation || TP53 Gene Inactivation || FGFR1 Gene Amplification


Recurrent Adult Acute Lymphoblastic Leukemia


Recurrent Extraskeletal Myxoid Chondrosarcoma

EWSR1-NR4A3 Fusion Protein Expression
TAF15-NR4A3 Fusion Protein Expression
TCF12-NR4A3 Fusion Protein Expression
TFG-NR4A3 Fusion Protein Expression

EWSR1-NR4A3 Fusion Protein Expression || TAF15-NR4A3 Fusion Protein Expression || TCF12-NR4A3 Fusion Protein Expression || TFG-NR4A3 Fusion Protein Expression


Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other


RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation


Oxyphilic Endometrial Endometrioid Adenocarcinoma

CTNNB1 Gene Mutation
Inactivating MLH1 Gene Mutation
Inactivating MSH2 Gene Mutation
KRAS Gene Amplification
PTEN Gene Inactivation

CTNNB1 Gene Mutation || Inactivating MLH1 Gene Mutation || Inactivating MSH2 Gene Mutation || KRAS Gene Amplification || PTEN Gene Inactivation


Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement


Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

EWSR1-ETV4 Fusion Protein Expression
EWSR1-ERG Fusion Protein Expression
EWSR1-ETV1 Fusion Protein Expression
EWSR1-FEV Fusion Protein Expression
EWSR1-PATZ1 Fusion Protein Expression
FUS-ERG Fusion Protein Expression
EWSR1-FLI1 Fusion Protein Expression

EWSR1-ETV4 Fusion Protein Expression || EWSR1-ERG Fusion Protein Expression || EWSR1-ETV1 Fusion Protein Expression || EWSR1-FEV Fusion Protein Expression || EWSR1-PATZ1 Fusion Protein Expression || FUS-ERG Fusion Protein Expression || EWSR1-FLI1 Fusion Protein Expression


Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma

Clonal T-Cell Receptor Beta Chain Gene Rearrangement

Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Gastroesophageal Junction Small Cell Carcinoma


Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7

CDKN2A Gene Inactivation
RASSF1A Gene Inactivation


Cystic Partially Differentiated Kidney Nephroblastoma


Extrahepatic Bile Duct Mucoepidermoid Carcinoma


TP53 Gene Inactivation
MYC Gene Amplification

TP53 Gene Inactivation || MYC Gene Amplification


Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma


Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7

NRAS Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation
PTEN Gene Inactivation
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation || PTEN Gene Inactivation || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


C-KIT Tyrosine Kinase Protein Overexpression || MYC Gene Amplification || NMYC Gene Amplification


Stage IIA Cutaneous Melanoma AJCC v6 and v7


Laryngeal Papillary Squamous Cell Carcinoma


Stage IB Esophageal Squamous Cell Carcinoma AJCC v7

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


PDGFRA Gene Mutation || KIT Gene Mutation


Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type

BRAF Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation


Gastrointestinal Stromal Tumor of the Gastrointestinal Tract


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Refractory Esophageal Squamous Cell Carcinoma


Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7

TP53 Gene Inactivation
KRAS Gene Amplification

TP53 Gene Inactivation || KRAS Gene Amplification


Mixed Cell Type Gastrointestinal Stromal Tumor


Prostate Adenocarcinoma with Neuroendocrine Differentiation

TMPRSS2-ERG Fusion Protein Expression
ERG Gene Rearrangement

TMPRSS2-ERG Fusion Protein Expression || ERG Gene Rearrangement


B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1

p190 Fusion Protein Expression || p210 Fusion Protein Expression || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System


Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type


Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement


Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells

BRCA2 Gene Mutation
CDKN2A Gene Inactivation
SMAD4/DPC4 Gene Inactivation
ERBB2 Gene Amplification
RB1 Gene Inactivation
TP53 Gene Inactivation
AKT2 Gene Amplification
KRAS Gene Mutation
MAP2K4 Gene Inactivation

BRCA2 Gene Mutation || CDKN2A Gene Inactivation || SMAD4/DPC4 Gene Inactivation || ERBB2 Gene Amplification || RB1 Gene Inactivation || TP53 Gene Inactivation || AKT2 Gene Amplification || KRAS Gene Mutation || MAP2K4 Gene Inactivation


GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


EWSR1-PATZ1 Fusion Protein Expression
CIC-DUX4 Fusion Protein Expression

EWSR1-PATZ1 Fusion Protein Expression || CIC-DUX4 Fusion Protein Expression


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Lung Non-Squamous Non-Small Cell Carcinoma

TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Locally Advanced Pituitary Gland Carcinoma


Unresectable Peritoneal Sarcomatoid Mesothelioma

CDKN2A Gene Inactivation
NF2 Gene Inactivation
BAP1 Gene Mutation

CDKN2A Gene Inactivation || NF2 Gene Inactivation || BAP1 Gene Mutation


EWSR1-ETV4 Fusion Protein Expression
EWSR1-ERG Fusion Protein Expression
EWSR1-ETV1 Fusion Protein Expression
EWSR1-FEV Fusion Protein Expression
EWSR1-PATZ1 Fusion Protein Expression
FUS-ERG Fusion Protein Expression
EWSR1-FLI1 Fusion Protein Expression

EWSR1-ETV4 Fusion Protein Expression || EWSR1-ERG Fusion Protein Expression || EWSR1-ETV1 Fusion Protein Expression || EWSR1-FEV Fusion Protein Expression || EWSR1-PATZ1 Fusion Protein Expression || FUS-ERG Fusion Protein Expression || EWSR1-FLI1 Fusion Protein Expression


Clinical Stage III Esophageal Adenocarcinoma AJCC v8

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8


C-KIT Tyrosine Kinase Protein Overexpression || MYC Gene Amplification || NMYC Gene Amplification


Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Recurrent Endometrial Endometrioid Adenocarcinoma

CTNNB1 Gene Mutation
Inactivating MLH1 Gene Mutation
Inactivating MSH2 Gene Mutation
KRAS Gene Amplification
PTEN Gene Inactivation

CTNNB1 Gene Mutation || Inactivating MLH1 Gene Mutation || Inactivating MSH2 Gene Mutation || KRAS Gene Amplification || PTEN Gene Inactivation


Cervical Esophagus Squamous Cell Carcinoma

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


PDGFRA Gene Mutation || KIT Gene Mutation


Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Pituitary Tumor Transforming Gene Overexpression


Locally Advanced Esophageal Squamous Cell Carcinoma


Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


Microsatellite Instability
CTNNB1 Gene Mutation
PTEN Gene Inactivation

Microsatellite Instability || CTNNB1 Gene Mutation || PTEN Gene Inactivation


Non-Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis


GNAQ Gene Mutation
GNA11 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation


Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm

BRAF Gene Mutation
TP53 Gene Inactivation
KRAS Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || KRAS Gene Mutation


Cervical Malignant Peripheral Nerve Sheath Tumor


Fibrin-Associated Diffuse Large B-Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement || NOTCH1 Gene Mutation


Stage IIA Lung Squamous Cell Carcinoma AJCC v7

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation


Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7

EGFR Protein Overexpression
TP53 Gene Inactivation
ERBB2 Protein Overexpression

EGFR Protein Overexpression || TP53 Gene Inactivation || ERBB2 Protein Overexpression


Ann Arbor Stage III Mantle Cell Lymphoma

Clonal CCND1 Gene Rearrangement
CCND1 Protein Overexpression

Clonal CCND1 Gene Rearrangement || CCND1 Protein Overexpression

Pituitary Tumor Transforming Gene Overexpression


Advanced Cervical Adenosquamous Carcinoma

ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Childhood Clear Cell Sarcoma of Soft Parts


TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
KRAS Gene Amplification
LKB1 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || KRAS Gene Amplification || LKB1 Gene Inactivation || EGFR Gene Mutation


Stage IV Thyroid Gland Follicular Carcinoma AJCC v7

NRAS Gene Mutation
PTEN Gene Inactivation
PPARG Gene Rearrangement
HRAS Gene Mutation
PIK3CA Gene Mutation
TERT Gene Mutation

NRAS Gene Mutation || PTEN Gene Inactivation || PPARG Gene Rearrangement || HRAS Gene Mutation || PIK3CA Gene Mutation || TERT Gene Mutation


Myelodysplastic Syndrome with Somatic Mutations

TP53 Gene Inactivation
RUNX1 Gene Mutation
EZH2 Gene Mutation
ETV6 Gene Mutation
ASXL1 Gene Mutation

TP53 Gene Inactivation || RUNX1 Gene Mutation || EZH2 Gene Mutation || ETV6 Gene Mutation || ASXL1 Gene Mutation


RB1 Gene Inactivation
FOS Gene Amplification

RB1 Gene Inactivation || FOS Gene Amplification


Stage I Acral Lentiginous Melanoma AJCC v7


Metastatic Ovarian Clear Cell Adenocarcinoma


High Grade B-Cell Lymphoma, Not Otherwise Specified

Clonal Immunoglobulin Heavy Chain Gene Rearrangement


GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


Stage III Lentigo Maligna Melanoma AJCC v7


CDKN2A Gene Inactivation
RASSF1A Gene Inactivation

CDKN2A Gene Inactivation || RASSF1A Gene Inactivation


Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


SS18-SSX1 Fusion Protein Expression
SS18-SSX2 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression

SS18-SSX1 Fusion Protein Expression || SS18-SSX2 Fusion Protein Expression || SS18-SSX4 Fusion Protein Expression


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Villoglandular Endometrial Endometrioid Adenocarcinoma

CTNNB1 Gene Mutation
Inactivating MLH1 Gene Mutation
Inactivating MSH2 Gene Mutation
KRAS Gene Amplification
PTEN Gene Inactivation

CTNNB1 Gene Mutation || Inactivating MLH1 Gene Mutation || Inactivating MSH2 Gene Mutation || KRAS Gene Amplification || PTEN Gene Inactivation


Polymerase Proofreading Associated Polyposis

POLE Gene Mutation || POLD1 Gene Mutation


BRAF Gene Mutation
TP53 Gene Inactivation
APC Gene Inactivation
KRAS Gene Amplification
MYC Gene Mutation

BRAF Gene Mutation || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Ciliary Body Benign Teratoid Medulloepithelioma


Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8


Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


Schistosoma Hematobium-Related Bladder Verrucous Carcinoma

EGFR Protein Overexpression
HRAS Gene Amplification
TP53 Gene Inactivation
ERBB2 Protein Overexpression

EGFR Protein Overexpression || HRAS Gene Amplification || TP53 Gene Inactivation || ERBB2 Protein Overexpression


Refractory Chronic Myelomonocytic Leukemia


Locally Advanced Unresectable Cervical Adenocarcinoma


Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma

Apoptotic Pathway Deregulation || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Thoracic Esophagus Squamous Cell Carcinoma

Aneuploidy
CCND1 Gene Amplification
CDKN2A Gene Inactivation
EGFR Gene Amplification
FGF4 Gene Amplification
FGF6 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

Aneuploidy || CCND1 Gene Amplification || CDKN2A Gene Inactivation || EGFR Gene Amplification || FGF4 Gene Amplification || FGF6 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma

NRAS Gene Mutation
KRAS Gene Mutation
RET/PTC Rearrangement
NTRK1 Gene Rearrangement
HRAS Gene Mutation
BRAF NP_004324.2:p.V600E

NRAS Gene Mutation || KRAS Gene Mutation || RET/PTC Rearrangement || NTRK1 Gene Rearrangement || HRAS Gene Mutation || BRAF NP_004324.2:p.V600E


FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Anaplastic (Malignant) Intraspinal Meningioma


Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8


Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8

CDKN2A Gene Inactivation
EGFR Gene Amplification
ERBB2 Gene Amplification
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation
Loss of E-cadherin Expression

CDKN2A Gene Inactivation || EGFR Gene Amplification || ERBB2 Gene Amplification || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation || Loss of E-cadherin Expression


CDKN2A Gene Inactivation
ERBB2 Gene Amplification
TP53 Gene Inactivation
KRAS Gene Mutation

CDKN2A Gene Inactivation || ERBB2 Gene Amplification || TP53 Gene Inactivation || KRAS Gene Mutation


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Stage II Adrenal Cortex Carcinoma AJCC v7


Metastatic Small Intestinal Adenocarcinoma

Microsatellite Instability
CTNNB1 Gene Mutation
SMAD4/DPC4 Gene Inactivation
TP53 Gene Inactivation
KRAS Gene Mutation
Loss of E-cadherin Expression

Microsatellite Instability || CTNNB1 Gene Mutation || SMAD4/DPC4 Gene Inactivation || TP53 Gene Inactivation || KRAS Gene Mutation || Loss of E-cadherin Expression


Ductal Breast Carcinoma In Situ, Solid Type

CCND1 Gene Amplification
Cyclin D1 Messenger RNA Overexpression
CCND1 Protein Overexpression
ERBB2 Gene Amplification
TP53 Gene Inactivation
ERBB2 Protein Overexpression

CCND1 Gene Amplification || Cyclin D1 Messenger RNA Overexpression || CCND1 Protein Overexpression || ERBB2 Gene Amplification || TP53 Gene Inactivation || ERBB2 Protein Overexpression


Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation

Microsatellite Instability
CTNNB1 Gene Mutation
PTEN Gene Inactivation

Microsatellite Instability || CTNNB1 Gene Mutation || PTEN Gene Inactivation


Microsatellite Instability
BRAF Gene Mutation

Microsatellite Instability || BRAF Gene Mutation


Splenic Manifestation of Chronic Lymphocytic Leukemia


Clonal CCND1 Gene Rearrangement
CCND1 Protein Overexpression

Clonal CCND1 Gene Rearrangement || CCND1 Protein Overexpression


Refractory Extranodal Diffuse Large B-cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement


TP53 Gene Inactivation
KRAS Gene Amplification
LKB1 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || KRAS Gene Amplification || LKB1 Gene Inactivation || EGFR Gene Mutation


CDKN2A Gene Deletion
RB1 Gene Inactivation
TP53 Gene Inactivation
PTEN Gene Inactivation

CDKN2A Gene Deletion || RB1 Gene Inactivation || TP53 Gene Inactivation || PTEN Gene Inactivation


BRAF Gene Mutation || High-Frequency Microsatellite Instability || TP53 Gene Inactivation || APC Gene Inactivation || KRAS Gene Amplification || MYC Gene Mutation


Posterior Tongue Adenoid Cystic Carcinoma


Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement || Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage


Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7


Minor Salivary Gland Mucoepidermoid Carcinoma


Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive

p190 Fusion Protein Expression
p210 Fusion Protein Expression
p230 Fusion Protein Expression

p190 Fusion Protein Expression || p210 Fusion Protein Expression || p230 Fusion Protein Expression


Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma

CDH1 Gene Inactivation
Loss of E-cadherin Expression

CDH1 Gene Inactivation || Loss of E-cadherin Expression


Clonal BCL2 Gene Rearrangement
Clonal BCL6 Gene Rearrangement

Clonal BCL2 Gene Rearrangement || Clonal BCL6 Gene Rearrangement


Stage I T Lymphoblastic Leukemia/Lymphoma

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement || NOTCH1 Gene Mutation


Sporadic Malignant Peripheral Nerve Sheath Tumor


B Lymphoblastic Lymphoma by Ann Arbor Stage

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement || Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Malignant Gastrointestinal Stromal Tumor

PDGFRA Gene Mutation || KIT Gene Mutation


TP53 Gene Inactivation
EGFR Gene Mutation

TP53 Gene Inactivation || EGFR Gene Mutation


Stage II Lung Squamous Cell Carcinoma AJCC v7

RB1 Gene Inactivation
TP53 Gene Inactivation
APC Gene Inactivation
FHIT Gene Inactivation

RB1 Gene Inactivation || TP53 Gene Inactivation || APC Gene Inactivation || FHIT Gene Inactivation


Stage III Adrenal Cortex Carcinoma AJCC v7


SS18-SSX1 Fusion Protein Expression
SS18-SSX2 Fusion Protein Expression
SS18-SSX4 Fusion Protein Expression

SS18-SSX1 Fusion Protein Expression || SS18-SSX2 Fusion Protein Expression || SS18-SSX4 Fusion Protein Expression


ERBB2 Gene Amplification
TP53 Gene Inactivation
MYC Gene Amplification
FHIT Gene Inactivation

ERBB2 Gene Amplification || TP53 Gene Inactivation || MYC Gene Amplification || FHIT Gene Inactivation


Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8

GNAQ Gene Mutation
GNA11 Gene Mutation
BAP1 Gene Mutation
SF3B1 Gene Mutation
CYSLTR2 Gene Mutation
PLCB4 Gene Mutation
EIF1AX Gene Mutation

GNAQ Gene Mutation || GNA11 Gene Mutation || BAP1 Gene Mutation || SF3B1 Gene Mutation || CYSLTR2 Gene Mutation || PLCB4 Gene Mutation || EIF1AX Gene Mutation


Penile Malignant Peripheral Nerve Sheath Tumor


Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement || Clonal T-Cell Receptor Gene Rearrangement


Refractory Endometrial Serous Adenocarcinoma


Stage IIIA Gastric Gastrointestinal Stromal Tumor


Digestive System Diffuse Large B-Cell Lymphoma

Clonal Immunoglobulin Heavy Chain Gene Rearrangement || Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement


Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

TP53 Gene Inactivation
MDM2 Gene Mutation

TP53 Gene Inactivation || MDM2 Gene Mutation


Refractory Childhood Acute Lymphoblastic Leukemia

Clonal T-Cell Receptor Beta Chain Gene Rearrangement || Clonal T-Cell Receptor Gamma Chain Gene Rearrangement


Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma


Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


Xeroderma Pigmentosum, Complementation Group F


Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative


Posterior Tongue Squamous Cell Carcinoma


Type 2 Diabetes Mellitus
Ovarian Carcinoma

Type 2 Diabetes Mellitus || Ovarian Carcinoma


Central Nervous System Degenerative Disorder


Invasive Ductal Carcinoma, Not Otherwise Specified


Parkinson's Disease || Anterior Tongue Squamous Cell Carcinoma || Posterior Tongue Squamous Cell Carcinoma


Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Rectal Carcinoma
Malignant Gastric Neoplasm
Breast Carcinoma
Lung Carcinoma

Rectal Carcinoma || Malignant Gastric Neoplasm || Breast Carcinoma || Lung Carcinoma


Chronic Lymphocytic Leukemia
Plasma Cell Myeloma
Gastric Carcinoma
Hepatocellular Carcinoma

Chronic Lymphocytic Leukemia || Plasma Cell Myeloma || Gastric Carcinoma || Hepatocellular Carcinoma


Acute Promyelocytic Leukemia with PML-RARA


Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative


Acute Lymphoblastic Leukemia || Psoriasis || Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Medulloblastoma || Hepatocellular Carcinoma


Alzheimer's Disease
Type 2 Diabetes Mellitus
Lung Carcinoma

Alzheimer's Disease || Type 2 Diabetes Mellitus || Lung Carcinoma


Meningioma
Thyroid Gland Follicular Carcinoma
Prostate Carcinoma
Oligodendroglioma

Meningioma || Thyroid Gland Follicular Carcinoma || Prostate Carcinoma || Oligodendroglioma


Central Nervous System Degenerative Disorder

Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1

Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Cockayne Syndrome || Xeroderma Pigmentosum, Complementation Group D || Trichothiodystrophy || Cerebrooculofacioskeletal Syndrome


Astrocytoma
Oligodendroglioma
Secondary Glioblastoma

Astrocytoma || Oligodendroglioma || Secondary Glioblastoma


B-Cell Non-Hodgkin Lymphoma
B-Cell Leukemia

B-Cell Non-Hodgkin Lymphoma || B-Cell Leukemia

Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Mycobacterial Infection
Tuberculosis
Helicobacter Pylori Infection

Mycobacterial Infection || Tuberculosis || Helicobacter Pylori Infection


Breast Carcinoma
Malignant Ovarian Neoplasm

Breast Carcinoma || Malignant Ovarian Neoplasm


Hemolytic Anemia || Myocardial Infarction


Brain Neoplasm
Colorectal Neoplasm
Prostate Neoplasm
Breast Neoplasm

Brain Neoplasm || Colorectal Neoplasm || Prostate Neoplasm || Breast Neoplasm


Invasive Ductal Carcinoma, Not Otherwise Specified


Osteogenesis Imperfecta
Osteoporosis
Dermatofibrosarcoma Protuberans

Osteogenesis Imperfecta || Osteoporosis || Dermatofibrosarcoma Protuberans


Acute Myeloid Leukemia
Myelodysplastic Syndrome

Acute Myeloid Leukemia || Myelodysplastic Syndrome


Glioblastoma
Oral Cavity Squamous Cell Carcinoma
Lung Carcinoma

Glioblastoma || Oral Cavity Squamous Cell Carcinoma || Lung Carcinoma


Porphyria Cutanea Tarda
Hepatoerythropoietic Porphyria

Porphyria Cutanea Tarda || Hepatoerythropoietic Porphyria


Burkitt Lymphoma
Thyroid Gland Carcinoma
Hepatocellular Carcinoma

Burkitt Lymphoma || Thyroid Gland Carcinoma || Hepatocellular Carcinoma


Burkitt Lymphoma || Acute Promyelocytic Leukemia with PML-RARA || Prostate Carcinoma || Lung Carcinoma || Ovarian Carcinoma


Glioblastoma
Melanoma
Thyroid Gland Carcinoma
Prostate Carcinoma
Breast Carcinoma
Lung Carcinoma
Hepatocellular Carcinoma
Ovarian Carcinoma

Glioblastoma || Melanoma || Thyroid Gland Carcinoma || Prostate Carcinoma || Breast Carcinoma || Lung Carcinoma || Hepatocellular Carcinoma || Ovarian Carcinoma


Hypertension
Acute Lymphoblastic Leukemia
Diffuse Large B-Cell Lymphoma
Pancreatic Carcinoma
Breast Carcinoma
Myeloproliferative Neoplasm

Hypertension || Acute Lymphoblastic Leukemia || Diffuse Large B-Cell Lymphoma || Pancreatic Carcinoma || Breast Carcinoma || Myeloproliferative Neoplasm


Alzheimer's Disease || Type 2 Diabetes Mellitus || Lung Carcinoma


Alzheimer's Disease
Atherosclerotic Cardiovascular Disease
Hyperlipoproteinemia

Alzheimer's Disease || Atherosclerotic Cardiovascular Disease || Hyperlipoproteinemia


Leukemia
Lymphoma
Breast Carcinoma
Lung Carcinoma
Hepatocellular Carcinoma

Leukemia || Lymphoma || Breast Carcinoma || Lung Carcinoma || Hepatocellular Carcinoma


Alzheimer's Disease
Parkinson's Disease
Lewy Body Dementia

Alzheimer's Disease || Parkinson's Disease || Lewy Body Dementia


Amyotrophic Lateral Sclerosis
Angiomatoid Fibrous Histiocytoma

Amyotrophic Lateral Sclerosis || Angiomatoid Fibrous Histiocytoma

Central Nervous System Degenerative Disorder


Polycystic Kidney Disease || Chronic Lymphocytic Leukemia || Acute Promyelocytic Leukemia with PML-RARA || Pituitary Gland Adenoma || Polycystic Liver Disease || Prostate Carcinoma || Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Acidic Fibroblast Growth Factor Intracellular-Binding Protein


Acquired Immunodeficiency Syndrome
Crohn Disease

Acquired Immunodeficiency Syndrome || Crohn Disease


Digestive System Neoplasm
Breast Carcinoma

Digestive System Neoplasm || Breast Carcinoma


Colorectal Carcinoma
Prostate Carcinoma
Breast Carcinoma
Bladder Carcinoma
Hepatocellular Carcinoma

Colorectal Carcinoma || Prostate Carcinoma || Breast Carcinoma || Bladder Carcinoma || Hepatocellular Carcinoma


Digestive System Neuroendocrine Tumor G1 || Thyroid Gland Carcinoma


Severe Combined Immunodeficiency with Absence of T and B Cells


Meningioma || Dermatofibrosarcoma Protuberans


Myeloid Leukemia
Cholangiocarcinoma
Breast Carcinoma

Myeloid Leukemia || Cholangiocarcinoma || Breast Carcinoma


Medulloblastoma || Hepatocellular Carcinoma


Severe Combined Immunodeficiency || Purine-Nucleoside Phosphorylase Deficiency


Posterior Tongue Squamous Cell Carcinoma


Neuroblastoma || Lung Small Cell Carcinoma


Adult T-Cell Leukemia/Lymphoma
Plasma Cell Myeloma

Adult T-Cell Leukemia/Lymphoma || Plasma Cell Myeloma


Rheumatoid Arthritis
Type 1 Diabetes Mellitus
Systemic Lupus Erythematosus
Hashimoto Thyroiditis

Rheumatoid Arthritis || Type 1 Diabetes Mellitus || Systemic Lupus Erythematosus || Hashimoto Thyroiditis


Acute Promyelocytic Leukemia with PML-RARA || Uterine Corpus Leiomyoma || Lung Carcinoma || Ovarian Carcinoma


Glioblastoma || Melanoma || Thyroid Gland Carcinoma || Prostate Carcinoma || Breast Carcinoma || Lung Carcinoma || Hepatocellular Carcinoma || Ovarian Carcinoma


Burkitt Lymphoma
Thyroid Gland Carcinoma
Hepatocellular Carcinoma

Burkitt Lymphoma || Thyroid Gland Carcinoma || Hepatocellular Carcinoma


Plasma Cell Myeloma || Brain Stem Glioma


Cholangiocarcinoma
Breast Carcinoma
Hepatocellular Carcinoma

Cholangiocarcinoma || Breast Carcinoma || Hepatocellular Carcinoma


Calcium Release-Activated Calcium Channel Protein 1

Tyrosine-Protein Phosphatase Non-Receptor Type 12


Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis

Rheumatoid Arthritis || Multiple Sclerosis || Psoriasis


Alzheimer's Disease
Atherosclerotic Cardiovascular Disease
Hyperlipoproteinemia

Alzheimer's Disease || Atherosclerotic Cardiovascular Disease || Hyperlipoproteinemia


Interferon-Induced Helicase C Domain-Containing Protein 1


Xeroderma Pigmentosum, Complementation Group A


Squamous Cell Carcinoma
Breast Carcinoma

Squamous Cell Carcinoma || Breast Carcinoma


Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative


Breast Carcinoma
Gastric Carcinoma
Hepatocellular Carcinoma

Breast Carcinoma || Gastric Carcinoma || Hepatocellular Carcinoma


Malignant Intestinal Neoplasm
Endometrial Carcinoma

Malignant Intestinal Neoplasm || Endometrial Carcinoma


Chronic Lymphocytic Leukemia
Hepatocellular Carcinoma

Chronic Lymphocytic Leukemia || Hepatocellular Carcinoma


Thyroid Gland Papillary Carcinoma || Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative


Lung Non-Small Cell Carcinoma
Celiac Disease
Type 1 Diabetes Mellitus
Hypothyroidism
Psoriasis

Lung Non-Small Cell Carcinoma || Celiac Disease || Type 1 Diabetes Mellitus || Hypothyroidism || Psoriasis


Acute Lymphoblastic Leukemia || Acute Myeloid Leukemia || Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Malignant Breast Neoplasm
Solid Neoplasm

Malignant Breast Neoplasm || Solid Neoplasm


Wilms Tumor
Rhabdomyosarcoma
Adrenal Cortex Carcinoma
Breast Carcinoma
Lung Carcinoma
Ovarian Carcinoma

Wilms Tumor || Rhabdomyosarcoma || Adrenal Cortex Carcinoma || Breast Carcinoma || Lung Carcinoma || Ovarian Carcinoma


Burkitt Lymphoma
Colorectal Carcinoma
Chronic Lymphocytic Leukemia
Obesity
Diffuse Large B-Cell Lymphoma
Bladder Carcinoma

Burkitt Lymphoma || Colorectal Carcinoma || Chronic Lymphocytic Leukemia || Obesity || Diffuse Large B-Cell Lymphoma || Bladder Carcinoma


Central Nervous System Degenerative Disorder


Familial Polycythemia || Erythroleukemia


Type 2 Diabetes Mellitus
Rhabdomyosarcoma
Lung Carcinoma
Nasopharyngeal Carcinoma

Type 2 Diabetes Mellitus || Rhabdomyosarcoma || Lung Carcinoma || Nasopharyngeal Carcinoma


Acute Lymphoblastic Leukemia
Nijmegen Breakage Syndrome

Acute Lymphoblastic Leukemia || Nijmegen Breakage Syndrome


Chronic Lymphocytic Leukemia
Plasma Cell Myeloma
Brain Stem Glioma

Chronic Lymphocytic Leukemia || Plasma Cell Myeloma || Brain Stem Glioma


Malignant Colorectal Neoplasm
Colorectal Adenoma

Malignant Colorectal Neoplasm || Colorectal Adenoma


Acute Promyelocytic Leukemia with PML-RARA


Childhood B Acute Lymphoblastic Leukemia


Severe Combined Immunodeficiency || Purine-Nucleoside Phosphorylase Deficiency


Pancreatic Carcinoma
Thyroid Gland Carcinoma

Pancreatic Carcinoma || Thyroid Gland Carcinoma


Beta/Gamma Crystallin Domain-Containing Protein 1

Aryl Hydrocarbon Receptor Nuclear Translocator 2


Acute Myeloid Leukemia
Non-Hodgkin Lymphoma
Myelodysplastic Syndrome

Acute Myeloid Leukemia || Non-Hodgkin Lymphoma || Myelodysplastic Syndrome


Prostate Carcinoma
Bladder Carcinoma
Hepatocellular Carcinoma

Prostate Carcinoma || Bladder Carcinoma || Hepatocellular Carcinoma


Myeloid Leukemia
Cholangiocarcinoma
Breast Carcinoma

Myeloid Leukemia || Cholangiocarcinoma || Breast Carcinoma


Chronic Lymphocytic Leukemia
Plasma Cell Myeloma
Gastric Carcinoma
Hepatocellular Carcinoma

Chronic Lymphocytic Leukemia || Plasma Cell Myeloma || Gastric Carcinoma || Hepatocellular Carcinoma


Osteomalacia || Rickets || Hypophosphatemia


Acquired Immunodeficiency Syndrome
Crohn Disease

Acquired Immunodeficiency Syndrome || Crohn Disease


Burkitt Lymphoma
Colorectal Carcinoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Prostate Carcinoma

Burkitt Lymphoma || Colorectal Carcinoma || Chronic Lymphocytic Leukemia || Diffuse Large B-Cell Lymphoma || Prostate Carcinoma


Alzheimer's Disease
Type 2 Diabetes Mellitus
Lung Carcinoma

Alzheimer's Disease || Type 2 Diabetes Mellitus || Lung Carcinoma


Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Hypertension
Acute Lymphoblastic Leukemia
Diffuse Large B-Cell Lymphoma
Pancreatic Carcinoma
Breast Carcinoma
Myeloproliferative Neoplasm

Hypertension || Acute Lymphoblastic Leukemia || Diffuse Large B-Cell Lymphoma || Pancreatic Carcinoma || Breast Carcinoma || Myeloproliferative Neoplasm


Plasma Cell Myeloma || Brain Stem Glioma


Alzheimer's Disease
Hepatitis
Hypoglycemia

Alzheimer's Disease || Hepatitis || Hypoglycemia


Invasive Ductal Carcinoma, Not Otherwise Specified || Colorectal Adenocarcinoma || Head and Neck Carcinoma

Proto-Oncogene Tyrosine-Protein Kinase Src

Regenerating Islet-Derived Protein 3-Alpha

CUB and Sushi Domain-Containing Protein 1


Meningioma
Thyroid Gland Follicular Carcinoma
Prostate Carcinoma
Oligodendroglioma

Meningioma || Thyroid Gland Follicular Carcinoma || Prostate Carcinoma || Oligodendroglioma


Cockayne Syndrome || Xeroderma Pigmentosum, Complementation Group D || Trichothiodystrophy || Cerebrooculofacioskeletal Syndrome


Polycystic Kidney Disease || Chronic Lymphocytic Leukemia || Acute Promyelocytic Leukemia with PML-RARA || Pituitary Gland Adenoma || Polycystic Liver Disease || Prostate Carcinoma || Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Colorectal Carcinoma
Leukemia
Lymphoma
Neuroblastoma
Thyroid Gland Carcinoma
Breast Carcinoma
Lung Carcinoma
Hepatocellular Carcinoma

Colorectal Carcinoma || Leukemia || Lymphoma || Neuroblastoma || Thyroid Gland Carcinoma || Breast Carcinoma || Lung Carcinoma || Hepatocellular Carcinoma


Acute Promyelocytic Leukemia with PML-RARA || Uterine Corpus Leiomyoma || Lung Carcinoma || Ovarian Carcinoma


Malignant Breast Neoplasm
Solid Neoplasm

Malignant Breast Neoplasm || Solid Neoplasm

Echinoderm Microtubule-Associated Protein-Like 4


Breast Carcinoma
Malignant Ovarian Neoplasm

Breast Carcinoma || Malignant Ovarian Neoplasm


Burkitt Lymphoma
Colorectal Carcinoma
Lung Carcinoma
Ovarian Carcinoma

Burkitt Lymphoma || Colorectal Carcinoma || Lung Carcinoma || Ovarian Carcinoma


Osteogenesis Imperfecta
Osteoporosis
Dermatofibrosarcoma Protuberans

Osteogenesis Imperfecta || Osteoporosis || Dermatofibrosarcoma Protuberans


Phosphoinositide 3-Kinase Regulatory Subunit 5


Glioblastoma
Oral Cavity Squamous Cell Carcinoma
Lung Carcinoma

Glioblastoma || Oral Cavity Squamous Cell Carcinoma || Lung Carcinoma


Neuroblastoma || Lung Small Cell Carcinoma


Cation-Independent Mannose-6 Phosphate Receptor

CAP-Gly Domain-Containing Linker Protein 1


Glioblastoma
Esophageal Carcinoma
Pancreatic Carcinoma
Prostate Carcinoma
Brain Stem Glioma
Breast Carcinoma
Gastric Carcinoma
Head and Neck Squamous Cell Carcinoma
Hepatocellular Carcinoma

Glioblastoma || Esophageal Carcinoma || Pancreatic Carcinoma || Prostate Carcinoma || Brain Stem Glioma || Breast Carcinoma || Gastric Carcinoma || Head and Neck Squamous Cell Carcinoma || Hepatocellular Carcinoma


Alzheimer's Disease || Type 2 Diabetes Mellitus || Lung Carcinoma


Alzheimer's Disease
Atherosclerotic Cardiovascular Disease
Hyperlipoproteinemia

Alzheimer's Disease || Atherosclerotic Cardiovascular Disease || Hyperlipoproteinemia


Leukemia
Lymphoma
Breast Carcinoma
Lung Carcinoma
Hepatocellular Carcinoma

Leukemia || Lymphoma || Breast Carcinoma || Lung Carcinoma || Hepatocellular Carcinoma


Alzheimer's Disease
Parkinson's Disease
Lewy Body Dementia

Alzheimer's Disease || Parkinson's Disease || Lewy Body Dementia


Amyotrophic Lateral Sclerosis
Angiomatoid Fibrous Histiocytoma

Amyotrophic Lateral Sclerosis || Angiomatoid Fibrous Histiocytoma


Chronic Lymphocytic Leukemia
Plasma Cell Myeloma
Gastric Carcinoma
Hepatocellular Carcinoma

Chronic Lymphocytic Leukemia || Plasma Cell Myeloma || Gastric Carcinoma || Hepatocellular Carcinoma


Porphyria Cutanea Tarda
Hepatoerythropoietic Porphyria

Porphyria Cutanea Tarda || Hepatoerythropoietic Porphyria


Digestive System Neoplasm
Breast Carcinoma

Digestive System Neoplasm || Breast Carcinoma


Medulloblastoma || Hepatocellular Carcinoma


Adult T-Cell Leukemia/Lymphoma
Plasma Cell Myeloma

Adult T-Cell Leukemia/Lymphoma || Plasma Cell Myeloma


Prostate Adenocarcinoma
High Grade Lymphoma
Lung Adenocarcinoma
Pancreatic Adenocarcinoma
Colon Adenocarcinoma
Breast Adenocarcinoma

Prostate Adenocarcinoma || High Grade Lymphoma || Lung Adenocarcinoma || Pancreatic Adenocarcinoma || Colon Adenocarcinoma || Breast Adenocarcinoma


Acute Myeloid Leukemia
Myelodysplastic Syndrome

Acute Myeloid Leukemia || Myelodysplastic Syndrome


Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Lymphoid Leukemia
Follicular Lymphoma
Mesothelioma
Sezary Syndrome
Germ Cell Tumor
Colon Carcinoma

Lymphoid Leukemia || Follicular Lymphoma || Mesothelioma || Sezary Syndrome || Germ Cell Tumor || Colon Carcinoma


Probable ATP-Dependent RNA Helicase DDX6


Acute Promyelocytic Leukemia with PML-RARA || Breast Carcinoma


Acute Promyelocytic Leukemia with PML-RARA || Uterine Corpus Leiomyoma || Lung Carcinoma || Ovarian Carcinoma


Childhood B Acute Lymphoblastic Leukemia


Meningioma || Dermatofibrosarcoma Protuberans


Medulloblastoma
Plasma Cell Myeloma
Hepatocellular Carcinoma

Medulloblastoma || Plasma Cell Myeloma || Hepatocellular Carcinoma


Burkitt Lymphoma || Acute Promyelocytic Leukemia with PML-RARA || Prostate Carcinoma || Lung Carcinoma || Ovarian Carcinoma


Cholangiocarcinoma
Breast Carcinoma
Hepatocellular Carcinoma

Cholangiocarcinoma || Breast Carcinoma || Hepatocellular Carcinoma


Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis

Rheumatoid Arthritis || Multiple Sclerosis || Psoriasis


Chronic Lymphocytic Leukemia
Hepatocellular Carcinoma

Chronic Lymphocytic Leukemia || Hepatocellular Carcinoma


Burkitt Lymphoma
Thyroid Gland Carcinoma
Hepatocellular Carcinoma

Burkitt Lymphoma || Thyroid Gland Carcinoma || Hepatocellular Carcinoma


Chronic Lymphocytic Leukemia
Plasma Cell Myeloma
Brain Stem Glioma

Chronic Lymphocytic Leukemia || Plasma Cell Myeloma || Brain Stem Glioma


Leukemia || Myelodysplastic/Myeloproliferative Neoplasm


Rectal Carcinoma
Malignant Gastric Neoplasm
Breast Carcinoma
Lung Carcinoma

Rectal Carcinoma || Malignant Gastric Neoplasm || Breast Carcinoma || Lung Carcinoma


Type 2 Diabetes Mellitus
Hypertension
Obesity

Type 2 Diabetes Mellitus || Hypertension || Obesity


Malignant Intestinal Neoplasm
Endometrial Carcinoma

Malignant Intestinal Neoplasm || Endometrial Carcinoma


Acquired Immunodeficiency Syndrome
Crohn Disease

Acquired Immunodeficiency Syndrome || Crohn Disease


Colorectal Carcinoma || Ovarian Carcinoma


Familial Polycythemia || Erythroleukemia


Medulloblastoma || Hepatocellular Carcinoma


Severe Combined Immunodeficiency || X-Linked Severe Combined Immunodeficiency


Chronic Lymphocytic Leukemia
Breast Carcinoma

Chronic Lymphocytic Leukemia || Breast Carcinoma


Porphyria Cutanea Tarda
Hepatoerythropoietic Porphyria

Porphyria Cutanea Tarda || Hepatoerythropoietic Porphyria


Acute Lymphoblastic Leukemia || Acute Myeloid Leukemia || Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Alzheimer's Disease
Esophageal Adenocarcinoma
Gastric Carcinoma

Alzheimer's Disease || Esophageal Adenocarcinoma || Gastric Carcinoma


Childhood B Acute Lymphoblastic Leukemia


Chronic Myelogenous Leukemia, BCR-ABL1 Positive


Acute Promyelocytic Leukemia with PML-RARA || Breast Carcinoma


Central Nervous System Degenerative Disorder || Breast Carcinoma || Malignant Ovarian Neoplasm


Malignant Breast Neoplasm
Solid Neoplasm

Malignant Breast Neoplasm || Solid Neoplasm


Malignant Colorectal Neoplasm
Colorectal Adenoma

Malignant Colorectal Neoplasm || Colorectal Adenoma


Osteosarcoma
Adrenal Cortex Carcinoma
Thyroid Gland Carcinoma
Breast Carcinoma
Hepatocellular Carcinoma
Nasopharyngeal Carcinoma

Osteosarcoma || Adrenal Cortex Carcinoma || Thyroid Gland Carcinoma || Breast Carcinoma || Hepatocellular Carcinoma || Nasopharyngeal Carcinoma


Wilms Tumor
Rhabdomyosarcoma
Adrenal Cortex Carcinoma
Breast Carcinoma
Lung Carcinoma
Ovarian Carcinoma

Wilms Tumor || Rhabdomyosarcoma || Adrenal Cortex Carcinoma || Breast Carcinoma || Lung Carcinoma || Ovarian Carcinoma


Prostate Carcinoma
Bladder Carcinoma
Hepatocellular Carcinoma

Prostate Carcinoma || Bladder Carcinoma || Hepatocellular Carcinoma


Pancreatic Carcinoma
Thyroid Gland Carcinoma

Pancreatic Carcinoma || Thyroid Gland Carcinoma


Ras-Related C3 Botulinum Toxin Substrate 1

Vasoactive Intestinal Polypeptide Receptor 2

Scavenger Receptor Cysteine-Rich Type 1 Protein M130


Natural Cytotoxicity Triggering Receptor 3

Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit


Plasma Membrane Calcium-Transporting ATPase 3


B-Cell CLL/Lymphoma 7 Protein Family Member C

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5


Acidic Leucine-Rich Nuclear Phosphoprotein 32 Family Member D

Sodium Channel Protein Type 1 Subunit Alpha


Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Aryl Hydrocarbon Receptor Nuclear Translocator 2


Peroxisomal Multifunctional Enzyme Type 2


Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit

BAG Family Molecular Chaperone Regulator 1


Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5


Spermatid-Specific Linker Histone H1-Like Protein


G/T Mismatch-Specific Thymine DNA Glycosylase

Natural Cytotoxicity Triggering Receptor 2

Ubiquitin Carboxyl-Terminal Hydrolase 17


Receptor-Type Tyrosine-Protein Phosphatase Gamma


Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 2 Protein


Probable ATP-Dependent RNA Helicase DDX6

Probable ATP-Dependent RNA Helicase DDX10


Killer Cell Lectin-Like Receptor Subfamily B Member 1

Transient Receptor Potential Cation Channel Subfamily M Member 5


Beta/Gamma Crystallin Domain-Containing Protein 1

Cellular Retinoic Acid-Binding Protein 1


Tumor Necrosis Factor Receptor Superfamily Member 12A

Cation-Independent Mannose-6 Phosphate Receptor


DNA Polymerase Epsilon Catalytic Subunit A


Proto-Oncogene Tyrosine-Protein Kinase Src


Carboxy-Terminal Domain RNA Polymerase II Polypeptide A Small Phosphatase 2

Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit


Breast Cancer Type 1 Susceptibility Protein


Tyrosine-Protein Phosphatase Non-Receptor Type 12


Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit

Probable ATP-Dependent RNA Helicase DDX10


B-Cell CLL/Lymphoma 7 Protein Family Member C


BMP/Retinoic Acid-Inducible Neural-Specific Protein 3


DNA Repair Protein Complementing XP-A Cells


Amyloid Beta A4 Precursor Protein-Binding Family A Member 2

Guanylate Cyclase Soluble Subunit Beta-1


BAG Family Molecular Chaperone Regulator 1

Melanoma-Derived Growth Regulatory Protein


Probable ATP-Dependent RNA Helicase DDX10


WW Domain-Containing Transcription Regulator Protein 1

Natural Cytotoxicity Triggering Receptor 3


Nucleolar and Spindle-Associated Protein 1


Eukaryotic Translation Initiation Factor 4E


SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 5


5-Aminolevulinate Synthase, Nonspecific, Mitochondrial

Serine/Threonine Protein Phosphatase 2B Catalytic Subunit Alpha Isoform

CDK5 Regulatory Subunit-Associated Protein 3


High Affinity cGMP-Specific 3',5'-Cyclic Phosphodiesterase 9A

V-Type Immunoglobulin Domain-Containing Suppressor of T-Cell Activation


1-Phosphatidylinositol 4,5-Bisphosphate Phosphodiesterase Beta-3


Multidrug Resistance-Associated Protein 4


Peptidyl-Prolyl Cis-Trans Isomerase F, Mitochondrial

Rho Guanine Nucleotide Exchange Factor 7

Probable ATP-Dependent RNA Helicase DDX6


Melanoma-Derived Growth Regulatory Protein


Mitotic Checkpoint Serine/Threonine-Protein Kinase BUB1


DNA Repair Protein Complementing XP-A Cells

Myocardin-Related Transcription Factor B


Endoplasmin
Heat Shock Protein HSP 90-Beta

Endoplasmin || Heat Shock Protein HSP 90-Beta


Phosphoinositide 3-Kinase Regulatory Subunit 5

Guanine Nucleotide-Binding Protein G(z) Subunit Alpha


Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1

Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Lysosome-Associated Membrane Glycoprotein 2


Interferon-Induced Helicase C Domain-Containing Protein 1


DNA Repair Protein Complementing XP-A Cells


Insulin-Like Growth Factor-Binding Protein 3

Transcription Initiation Factor TFIID Subunit 10


Progonadoliberin-2 || Gonadoliberin-2 || GNRH2 Gene Product


SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily B Member 1


B-Cell CLL/Lymphoma 7 Protein Family Member C


Abnormal Spindle-Like Microcephaly-Associated Protein

Zinc Finger MYND Domain-Containing Protein 10

Pre-B-Cell Leukemia Transcription Factor 1


Receptor-Type Tyrosine-Protein Phosphatase Gamma

Phosphofurin Acidic Cluster Sorting Protein 1


Calmodulin-Binding Transcription Activator 1


Fibroblast Growth Factor Receptor-Like 1


5-Aminolevulinate Synthase, Nonspecific, Mitochondrial


Major Facilitator Superfamily Domain-Containing Protein 8

BMP/Retinoic Acid-Inducible Neural-Specific Protein 3


Regenerating Islet-Derived Protein 3-Alpha

CUB and Sushi Domain-Containing Protein 1


Vascular Endothelial Growth Factor Receptor 1

Tumor Necrosis Factor Receptor Superfamily Member 12A


ELKS/Rab6-Interacting/CAST Family Member 1


Natural Cytotoxicity Triggering Receptor 2

G/T Mismatch-Specific Thymine DNA Glycosylase


Lysosome-Associated Membrane Glycoprotein 1


Biorientation of Chromosomes in Cell Division Protein 1-Like 1

A Disintegrin and Metalloprotease with Thrombospondin Motifs 1


Multidrug Resistance-Associated Protein 4

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5


Microtubule-Actin Cross-Linking Factor 1, Isoforms 1/2/3/5

Caspase Recruitment Domain-Containing Protein 11


Transcription Initiation Factor TFIID Subunit 10


Carboxy-Terminal Domain RNA Polymerase II Polypeptide A Small Phosphatase 2


Ras-Responsive Element-Binding Protein 1

Transcription Initiation Factor TFIID Subunit 8


Lysosome-Associated Membrane Glycoprotein 2

Guanylate Cyclase Soluble Subunit Beta-1


A Disintegrin and Metalloprotease with Thrombospondin Motifs 1


H19 Imprinted Maternal Untranslated mRNA


Ras-Related C3 Botulinum Toxin Substrate 1


Mitogen-Activated Protein Kinase Kinase Kinase 7

Biorientation of Chromosomes in Cell Division Protein 1-Like 1


Scavenger Receptor Cysteine-Rich Type 1 Protein M130

G/T Mismatch-Specific Thymine DNA Glycosylase

Coiled-Coil-Helix-Coiled-Coil-Helix Domain-Containing Protein 7


Mediator of DNA Damage Checkpoint Protein 1


Signal Transducer and Activator of Transcription 6

Mitogen-Activated Protein Kinase Kinase Kinase 7


Mitochondrial Import Inner Membrane Translocase Subunit TIM14

ATP-Binding Cassette Sub-Family G Member 1


Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit

Interferon-Induced Helicase C Domain-Containing Protein 1


Proto-Oncogene Tyrosine-Protein Kinase Src


Proto-Oncogene Tyrosine-Protein Kinase Src

CUB and Sushi Domain-Containing Protein 1

Probable ATP-Dependent RNA Helicase DDX6


Ciliary-Associated Calcium-Binding Coiled-Coil Protein 1


Natural Cytotoxicity Triggering Receptor 3


ATP-Binding Cassette Sub-Family B Member 5


Platelet-Derived Growth Factor Receptor Alpha

Vasoactive Intestinal Polypeptide Receptor 2

Membrane-Associated Guanylate Kinase, WW and PDZ Domain-Containing Protein 1


PiggyBac Transposable Element-Derived Protein 5

Peroxisomal Multifunctional Enzyme Type 2

Plasma Membrane Calcium-Transporting ATPase 3


ELKS/Rab6-Interacting/CAST Family Member 1


CDK5 Regulatory Subunit-Associated Protein 3


Neuronal Acetylcholine Receptor Subunit Alpha-5

Neutral and Basic Amino Acid Transport Protein rBAT

Transient Receptor Potential Cation Channel Subfamily M Member 5


CAP-Gly Domain-Containing Linker Protein 1


Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Cellular Retinoic Acid-Binding Protein 1


A Disintegrin and Metalloprotease with Thrombospondin Motifs 1

Disintegrin and Metalloproteinase Domain-Containing Protein 8


Pyruvate Dehydrogenase Protein X Component, Mitochondrial


Melanoma-Derived Growth Regulatory Protein

Lysosome-Associated Membrane Glycoprotein 2


Mediator of DNA Damage Checkpoint Protein 1


Eukaryotic Translation Initiation Factor 4E


Breast Cancer Type 1 Susceptibility Protein


Cancer/Testis Antigen 2
Cancer/Testis Antigen 2 Isoform LAGE-1A
CTAG2 Gene Product

Cancer/Testis Antigen 2 || Cancer/Testis Antigen 2 Isoform LAGE-1A || CTAG2 Gene Product

Echinoderm Microtubule-Associated Protein-Like 4


Natural Cytotoxicity Triggering Receptor 2


Myocardin-Related Transcription Factor B

Aryl Hydrocarbon Receptor Nuclear Translocator 2

Vasoactive Intestinal Polypeptide Receptor 2


Calmodulin-Binding Transcription Activator 1

Multidrug Resistance-Associated Protein 4


Serine/Threonine Protein Phosphatase 2B Catalytic Subunit Alpha Isoform

Natural Cytotoxicity Triggering Receptor 2


Histone H3
Histone H3.3
Histone H3.1
Histone H3.2
Histone H3.1t
Histone H3.3C
Histone H3.Y
Histone H3-Like Centromeric Protein A

Histone H3 || Histone H3.3 || Histone H3.1 || Histone H3.2 || Histone H3.1t || Histone H3.3C || Histone H3.Y || Histone H3-Like Centromeric Protein A


Natural Cytotoxicity Triggering Receptor 3


Disintegrin and Metalloproteinase Domain-Containing Protein 8


Mitotic Checkpoint Serine/Threonine-Protein Kinase BUB1


Ubiquitin Carboxyl-Terminal Hydrolase 17

G/T Mismatch-Specific Thymine DNA Glycosylase


Tumor Necrosis Factor Receptor Superfamily Member 19

Nuclear Pore Complex-Interacting Protein Family Member B8


Low Molecular Weight Phosphotyrosine Protein Phosphatase


Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 2 Protein

Phosphofurin Acidic Cluster Sorting Protein 1


DNA Repair Protein Complementing XP-C Cells

Probable ATP-Dependent RNA Helicase DDX10


Vasoactive Intestinal Polypeptide Receptor 2

Natural Cytotoxicity Triggering Receptor 2

Myocardin-Related Transcription Factor B


H19 Imprinted Maternal Untranslated mRNA


Transient Receptor Potential Cation Channel Subfamily M Member 5

Microtubule-Actin Cross-Linking Factor 1, Isoforms 1/2/3/5

Neuronal Acetylcholine Receptor Subunit Alpha-5


Coiled-Coil-Helix-Coiled-Coil-Helix Domain-Containing Protein 7

Scavenger Receptor Cysteine-Rich Type 1 Protein M130


Probable ATP-Dependent RNA Helicase DDX6

Proto-Oncogene Tyrosine-Protein Kinase Src

Peptidyl-Prolyl Cis-Trans Isomerase F, Mitochondrial


Amyloid Beta A4 Precursor Protein-Binding Family A Member 2


Echinoderm Microtubule-Associated Protein-Like 4


Pyruvate Dehydrogenase Protein X Component, Mitochondrial


Ciliary-Associated Calcium-Binding Coiled-Coil Protein 1


Dimethylaniline Monooxygenase [N-Oxide-Forming] 3

Nucleolar and Spindle-Associated Protein 1


Lysosome-Associated Membrane Glycoprotein 1

Nucleolar and Spindle-Associated Protein 1


Coiled-Coil-Helix-Coiled-Coil-Helix Domain-Containing Protein 7

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5


CDK5 Regulatory Subunit-Associated Protein 3


Natural Cytotoxicity Triggering Receptor 2

Serine/Threonine Protein Phosphatase 2B Catalytic Subunit Alpha Isoform


Sperm Protein Associated With the Nucleus on the X Chromosome B/F

Lysosome-Associated Membrane Glycoprotein 1


3-Phosphoinositide-Dependent Protein Kinase 1

Plasma Membrane Calcium-Transporting ATPase 3


General Transcription Factor IIH Subunit 3


Acidic Fibroblast Growth Factor Intracellular-Binding Protein


Membrane-Associated Guanylate Kinase, WW and PDZ Domain-Containing Protein 1

Neutral and Basic Amino Acid Transport Protein rBAT


Tumor Necrosis Factor Ligand Superfamily Member 6


Lysosome-Associated Membrane Glycoprotein 1

Guanylate Cyclase Soluble Subunit Beta-1


Phosphofurin Acidic Cluster Sorting Protein 1

Melanoma-Derived Growth Regulatory Protein


BAG Family Molecular Chaperone Regulator 1


Zinc Finger MYND Domain-Containing Protein 10


Neurogenic Locus Notch Homolog Protein 3


Tyrosine-Protein Phosphatase Non-Receptor Type 12

Calcium Release-Activated Calcium Channel Protein 1


Ras-Responsive Element-Binding Protein 1


Natural Cytotoxicity Triggering Receptor 3


Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 Protein

Lysosome-Associated Membrane Glycoprotein 2


Phosphoinositide 3-Kinase Regulatory Subunit 5

Proto-Oncogene Tyrosine-Protein Kinase Src


Transcription Initiation Factor TFIID Subunit 8

Receptor-Type Tyrosine-Protein Phosphatase Gamma


CUB and Sushi Domain-Containing Protein 1

Regenerating Islet-Derived Protein 3-Alpha


CDK5 Regulatory Subunit-Associated Protein 3


Neutral and Basic Amino Acid Transport Protein rBAT

Cation-Independent Mannose-6 Phosphate Receptor

Membrane-Associated Guanylate Kinase, WW and PDZ Domain-Containing Protein 1


Zinc Finger MYND Domain-Containing Protein 10

B-Cell CLL/Lymphoma 7 Protein Family Member C


Ras-Related C3 Botulinum Toxin Substrate 1

Leucine-Rich Repeats and Immunoglobulin-Like Domains Protein 1

Pre-B-Cell Leukemia Transcription Factor 1


Mediator of RNA Polymerase II Transcription Subunit 23


Interferon-Induced Helicase C Domain-Containing Protein 1


ATP-Binding Cassette Sub-Family G Member 1

SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily A Member 5

Tumor Necrosis Factor Receptor Superfamily Member 19

Mitochondrial Import Inner Membrane Translocase Subunit TIM14


Sperm Protein Associated With the Nucleus on the X Chromosome B/F


Receptor-Type Tyrosine-Protein Phosphatase Gamma


DNA Repair Protein Complementing XP-C Cells


H19 Imprinted Maternal Untranslated mRNA


BMP/Retinoic Acid-Inducible Neural-Specific Protein 3

Major Facilitator Superfamily Domain-Containing Protein 8


Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Rap Guanine Nucleotide Exchange Factor-Like 1

Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2


Sperm Protein Associated With the Nucleus on the X Chromosome A


39S Ribosomal Protein L45, Mitochondrial

Enoyl-CoA Hydratase Domain-Containing Protein 3, Mitochondrial


A Disintegrin and Metalloprotease with Thrombospondin Motifs 1

Calmodulin-Binding Transcription Activator 1


ATP-Binding Cassette Sub-Family B Member 5


Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 2

Serine/Threonine Protein Phosphatase 2B Catalytic Subunit Alpha Isoform


Peroxisomal Multifunctional Enzyme Type 2

PiggyBac Transposable Element-Derived Protein 5


BAG Family Molecular Chaperone Regulator 1

Acidic Leucine-Rich Nuclear Phosphoprotein 32 Family Member D


Microtubule-Actin Cross-Linking Factor 1, Isoforms 1/2/3/5


Insulin-Like Growth Factor-Binding Protein 5

Transcription Initiation Factor TFIID Subunit 10


ELKS/Rab6-Interacting/CAST Family Member 1

Na(+)/H(+) Exchange Regulatory Cofactor NHE-RF3


Guanylate Cyclase Soluble Subunit Beta-1

Mitogen-Activated Protein Kinase Kinase Kinase 7

Lysosome-Associated Membrane Glycoprotein 2


Melanoma-Derived Growth Regulatory Protein


Abnormal Spindle-Like Microcephaly-Associated Protein


High Affinity cGMP-Specific 3',5'-Cyclic Phosphodiesterase 9A

5-Aminolevulinate Synthase, Nonspecific, Mitochondrial

Serine/Threonine-Protein Phosphatase PP1-Alpha Catalytic Subunit